Vaccination is commonly used to minimize disease impacts on birds and promote sustainable poultry production. Vaccination against highly pathogenic avian influenza (HPAI) differs because HPAI is classified as a foreign animal disease in the US and disease control falls under federal jurisdiction. Vaccination for HPAI could negatively affect the nation's ability to export poultry and poultry products, representing the largest barrier to implementation. However, the continued burden of global HPAI cases requires a reevaluation of the cost of ongoing outbreaks and the need for new mitigation strategies, including HPAI vaccine use.
Kromm et al. (Fri,) studied this question.